Insider buying at Pulmonx Corp signals confidence despite a steep drop—explore why executives are buying, the company’s COPD pipeline, and upside potential.
June 1 insider sales at Pulmonx reveal routine tax‑settlement activity, highlighting the company’s thin liquidity, regulatory challenges and growth opportunities in bronchoscopic devices.
Pulmonx insider trades reveal tax‑planning moves and RSU confidence; investors eye Q4 earnings to gauge if its VARDIS platform can lift a distressed stock.